inTest Releases Q4 Earnings and 2026 Outlook
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 1 hour ago
0mins
Should l Buy INTT?
Source: seekingalpha
- Earnings Beat: inTest's Q4 non-GAAP EPS of $0.16 exceeded expectations by $0.05, demonstrating robust profitability despite a 10.4% year-over-year revenue decline to $32.8 million, which still surpassed estimates by $1.57 million, indicating resilience amid market challenges.
- Future Revenue Guidance: For Q1 2026, inTest projects revenue between $31 million and $33 million, above the consensus of $28.85 million, with an expected gross margin of approximately 44%, reflecting proactive management in cost control and market demand.
- Annual Financial Outlook: For the full year 2026, inTest anticipates revenue between $125 million and $130 million, with a gross margin of around 45% and operating expenses of $53 million to $55 million, indicating a cautious approach to business expansion.
- Capital Expenditure Plans: Capital expenditures are expected to be approximately 1% to 2% of revenue, with amortization expenses of $2.6 million and interest expenses of $0.3 million, reflecting a prudent financial strategy aimed at supporting future growth and investments.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy INTT?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on INTT
Wall Street analysts forecast INTT stock price to fall
2 Analyst Rating
1 Buy
1 Hold
0 Sell
Moderate Buy
Current: 10.220
Low
10.00
Averages
10.00
High
10.00
Current: 10.220
Low
10.00
Averages
10.00
High
10.00
About INTT
inTEST Corporation is a global supplier of test and process technology solutions for use in manufacturing and testing in key target markets. Its segments include Electronic Test, Environmental Technologies and Process Technologies. The Electronic Test segment consists of inTEST EMS, which has operations in New Jersey and California, and Acculogic, which has operations in Canada, California and Germany, and Alfamation S.p.A., which has operations in Italy and China. The Environmental Technologies segment consists of inTEST Thermal Solutions (iTS), which manufactures and sells products under the Temptronic, Sigma, Thermonics and North Sciences brand names and has operations in Massachusetts, Germany and Singapore. The Process Technologies segment consists of Ambrell and Videology. Ambrell provides customers with induction heating solutions for a wide variety of manufacturing processes. Videology is a designer, developer and manufacturer of digital streaming and image-capturing solutions.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Earnings Announcement: inTest (INTT) is scheduled to release its Q4 earnings on February 27 before market open, with a consensus EPS estimate of $0.11, reflecting a significant year-over-year decline of 52.2%, indicating pressure on profitability.
- Revenue Decline: The expected revenue for Q4 is $31.23 million, down 14.7% year-over-year, highlighting the company's struggles with revenue growth amid increasing market competition and weakening demand.
- Historical Performance Review: Over the past two years, inTest has beaten EPS estimates 63% of the time but only 25% of the time for revenue estimates, showcasing volatility in its earnings capability and challenges in meeting market expectations.
- Investor Conference Participation: inTest will also present at the 14th Annual NYC Summit, which may enhance its visibility among investors, providing an opportunity to attract attention despite current financial performance challenges.
See More
- Earnings Performance: inTEST Corporation reported a net income of $1.243 million for Q4, translating to $0.10 per share, which is a decline from last year's $1.504 million and $0.12 per share, indicating a weakening profitability.
- Revenue Decline: The company's revenue for the fourth quarter fell by 10.3% to $32.822 million from $36.603 million last year, reflecting a negative impact on performance due to soft market demand.
- Adjusted Earnings: Excluding special items, inTEST reported adjusted earnings of $1.953 million or $0.16 per share, showing a decline but still indicating some level of profitability.
- Future Outlook: The company projects revenues for fiscal 2026 to reach between $125 million and $130 million, up from $113.825 million in fiscal 2025, demonstrating management's confidence in future market conditions.
See More
- Earnings Beat: inTest's Q4 non-GAAP EPS of $0.16 exceeded expectations by $0.05, demonstrating robust profitability despite a 10.4% year-over-year revenue decline to $32.8 million, which still surpassed estimates by $1.57 million, indicating resilience amid market challenges.
- Future Revenue Guidance: For Q1 2026, inTest projects revenue between $31 million and $33 million, above the consensus of $28.85 million, with an expected gross margin of approximately 44%, reflecting proactive management in cost control and market demand.
- Annual Financial Outlook: For the full year 2026, inTest anticipates revenue between $125 million and $130 million, with a gross margin of around 45% and operating expenses of $53 million to $55 million, indicating a cautious approach to business expansion.
- Capital Expenditure Plans: Capital expenditures are expected to be approximately 1% to 2% of revenue, with amortization expenses of $2.6 million and interest expenses of $0.3 million, reflecting a prudent financial strategy aimed at supporting future growth and investments.
See More
- Significant Order Growth: In Q4 2025, InTest reported orders of $37.5 million, reflecting a 22.2% year-over-year increase, driven by sustained demand in the Auto/EV and Life Sciences sectors, enhancing the company's competitive position in diversified markets.
- Gross Margin Improvement: The gross margin increased from 41.9% in the previous quarter to 45.4%, primarily due to enhanced manufacturing efficiencies and new product sales, indicating success in cost control and product innovation.
- Strong Backlog: As of December 31, 2025, the backlog reached $53.9 million, up 9.4% sequentially and 36.4% year-over-year, providing a solid foundation for future revenue growth.
- Financial Resilience: The company reduced total debt by $7.6 million in 2025, maintaining a strong balance sheet that demonstrates resilience and sustained profitability amid economic uncertainties.
See More
- Stock Performance: inTest Corporation's shares rallied 8.9% in the last trading session to close at $8.72, with notable trading volume indicating strong market confidence in its future performance.
- Order Growth: The company is benefiting from record order growth and robust demand in the auto, EV, and defense sectors, supporting expectations for a gradual recovery, despite a quarterly EPS estimate of $0.16, reflecting a 30.4% year-over-year decline.
- Revenue Expectations: Expected revenues of $31.74 million represent a 13.3% decline from the previous year, yet optimism remains due to successful new product adoption and higher conversion rates, which may drive future growth.
- Analyst Rating: Currently holding a Zacks Rank of #3 (Hold), inTest's stock may struggle to maintain upward momentum in the absence of earnings estimate revisions, prompting investors to closely monitor upcoming developments.
See More
- Executive Participation: InTest's President and CEO Nick Grant, along with CFO Duncan Gilmour, will attend the 14th Annual NYC Summit on December 16, 2025, at Mastro's Steakhouse in New York, showcasing the company's innovative technologies in key markets such as semiconductors, automotive, and life sciences.
- Investor Engagement: The summit will feature a
See More








